Product Information
GUAIFENESIN 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0323 per EA under NDC 00904515460. Its NADAC has been published 654 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904515460
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/5/2009
Pharmacological Classes
Price Statistics
The NADAC for GUAIFENESIN 200 MG TABLET has been published 654 times since Nov 28, 2013, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0323 per EA |
|---|---|
| All-time high | $0.0501 (Mar 15, 2017) |
| All-time low | $0.0305 (Jan 21, 2015) |
| 52-week high | $0.0330 |
| 52-week low | $0.0314 |
| Median price | $0.0364 |
| Average price | $0.0371 |
| Largest weekly change | +40.1% (Jul 18, 2018) |
| Weeks tracked | 654 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUAIFENESIN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUAIFENESIN 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0323 per EA (NDC 00904515460), effective Sep 30, 2026.
How has the price of GUAIFENESIN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUAIFENESIN 200 MG TABLET has declined 16.5%. It has been tracked across 654 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GUAIFENESIN 200 MG TABLET?
Since Nov 28, 2013, the NADAC for GUAIFENESIN 200 MG TABLET has ranged from a low of $0.0305 (Jan 21, 2015) to a high of $0.0501 (Mar 15, 2017), with a median of $0.0364 per EA.
Are there cheaper alternatives to GUAIFENESIN 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of GUAIFENESIN 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GUAIFENESIN 200 MG TABLET?
GUAIFENESIN 200 MG TABLET (NDC 00904515460) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.